trial

ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry

NCTId NCT00264069

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

Phase — · Completed

Enrollment 2,622 (actual)

Sponsored by Janssen-Cilag Farmaceutica Ltda.

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Completed

Enrollment

2,622 (actual)

Study type

Observational

Allocation

—

Model

—

Masking

—

Start

2005-06

Primary completion

—

Eligibility

ALL · 18 Years

Interventions & indications

Drugs

Antipsychotic antidepressants

Indications

Bipolar Disorder Personality Disorders Personality Disorder Depression Schizophrenia Bipolar Disorder Schizophrenia Depression Patient Compliance

Sites

0 total

Facts & assertions

3 sourced

Enrollment

2,622

Phase

Status

COMPLETED

relationships

The graph out of here

drug

Antipsychotic

drug

antidepressants

drug

lead_sponsor

Janssen-Cilag Farmaceutica Ltda.

company

indication

Bipolar Disorder

indication

Personality Disorders

indication

Personality Disorder

indication